Sacituzumab govitecan continues to improve OS for ET-resistant HR+/HER2-mBC, and QoL update
Sacituzumab govitecan continues to improve OS for ET-resistant HR+/HER2-mBC, and QoL update
HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan
Scientists discover mechanism of action and an actionable inflammatory axis for air pollution induced NSCLC
How air pollution may trigger lung cancer in never-smokers
Tumour-infiltrating lymphocyte treatment for advanced melanoma
Nirogacestat success for desmoid tumours
Global obstacles to lung cancer screening: Report
IASLC Early Detection and Screening Committee: Global obstacles to lung cancer screening
Personalised smoking cessation support in a lung cancer screening programme
Early diagnosis needed for young adults with lung cancer
Philippines Choosing Wisely guidelines
MCI and FAU collaborate to create a Cancer Centre of Excellence